Today: 21 May 2026
XRP price today edges higher on Ripple’s Luxembourg nod as U.S. crypto rules move forward
14 January 2026
2 mins read

XRP price today edges higher on Ripple’s Luxembourg nod as U.S. crypto rules move forward

New York, January 14, 2026, 14:00 EST — Regular session

  • XRP rose roughly 1% to $2.13 following Ripple’s announcement of a new licensing milestone in Europe
  • U.S. lawmakers are advancing a market-structure bill that would divide regulatory oversight between the SEC and CFTC
  • Traders are focused on Thursday’s Senate Banking Committee markup, looking for any changes that might alter the timeline

XRP ticked up Wednesday after Ripple announced it had secured preliminary approval for an Electronic Money Institution (EMI) licence in Luxembourg. The token last traded 1.1% higher at $2.13, having ranged between $2.10 and $2.19 in the previous 24 hours. Bitcoin and ether also saw gains, according to CoinMarketCap. Ripple President Monica Long highlighted that Europe’s regulatory framework provides financial firms “the certainty” needed to shift blockchain projects beyond pilot phases to full commercial rollout. Meanwhile, Europe chief Cassie Craddock described Luxembourg as a “premier hub for financial innovation.” Ripple

This move is significant since XRP often acts like a political weather vane. Just a few words from regulators or discussions in Washington can quickly shift flows, particularly in altcoins still burdened by heavy regulatory uncertainty.

Luxembourg’s approval plays a key role here. An EMI licence allows companies to issue electronic money and offer regulated payment services. Ripple aims to use this licence to grow its cross-border payments footprint throughout Europe.

U.S. senators in Washington rolled out a draft market-structure bill late Monday aiming to clarify when crypto tokens qualify as securities or commodities. The legislation would also boost the Commodity Futures Trading Commission’s oversight of spot markets, where tokens are directly bought and sold. Summer Mersinger, CEO of the Blockchain Association, said bank lobbyists are mounting a “relentless pressure campaign,” while Digital Chamber CEO Cody Carbone described the progress as “encouraging.” The bill seeks to curb interest payments tied solely to holding dollar-pegged stablecoins, a key sticking point between banks and crypto firms. With the 2026 midterms looming, the proposal faces a narrow political window. Reuters

The Senate Banking Committee scheduled a procedural markup for Thursday on the CLARITY Act, a market-structure bill designed to clearly define the boundaries between the SEC and the CFTC.

Analysts say regulation is the key short-term catalyst. “Regulatory developments in Washington are also helping support sentiment,” LMAX Group strategist Joel Kruger noted this week, as investors shifted their focus back to the sector. Barron’s

Crypto-linked stocks showed a mixed performance in U.S. trading. Coinbase edged up a bit, Strategy climbed about 2.5%, and Robinhood dropped close to 2%. Bitcoin miners Riot Platforms and Marathon Digital both pushed higher.

But those tailwinds remain fragile. Ripple’s go-ahead in Luxembourg is only preliminary and comes with strings attached. The U.S. bill could still be amended or postponed — and when bitcoin falters, smaller tokens usually take the brunt as risk appetite wanes.

Traders face their next hurdle Thursday, January 15, as senators begin public markup of the legislation. The key issue: will the bill maintain its current form — particularly the SEC–CFTC division — or will new amendments emerge that could stall progress?

Stock Market Today

  • Clean Harbors (CLH) Valuation Amidst Recent Price Surge: Undervalued or Overpriced?
    May 21, 2026, 1:51 PM EDT. Clean Harbors (CLH) shares rose 19.7% year-to-date, currently trading around $291.40 after a recent dip. The company, a major North American environmental services provider, has attracted investor focus on its growth prospects and operational risks. A Discounted Cash Flow (DCF) analysis estimates an intrinsic value of $405.74 per share, suggesting CLH is undervalued by 28.2% despite a modest valuation score of 2/6 from Simply Wall St. The DCF model projects increasing free cash flow, reaching $830 million by 2030. However, price-to-earnings (P/E) considerations, reflecting investor expectations for growth versus risk, remain critical in evaluating fair value. Investors should weigh these metrics before deciding on exposure to CLH amid volatility.

Latest articles

Navitas Jumps Again as Next AI Power Trade Test Hits

Navitas Jumps Again as Next AI Power Trade Test Hits

21 May 2026
Navitas Semiconductor shares jumped 5.3% to $24.20 on Thursday, hitting a new intraday and near 52-week high, with over 22 million shares traded. The move followed news that CEO Chris Allexandre and CFO Tonya Stevens will meet investors at upcoming Craig-Hallum and Evercore conferences. Navitas reported Q1 revenue of $8.6 million, up 18% sequentially but down year-over-year.
Micron Beats Market as Samsung Deal Lifts Shares

Micron Beats Market as Samsung Deal Lifts Shares

21 May 2026
Micron shares climbed $14.82 to $746.81 on Thursday, outperforming the SMH semiconductor ETF and QQQ, which both fell. The rally followed Samsung’s suspension of a planned 18-day strike by 48,000 union members after a tentative pay deal. Micron’s operations chief said demand continues to outpace supply. Samsung union members will vote on the agreement between May 22 and May 27.
Wall Street Turned to Musk’s SpaceX After Tesla’s Brief Rally

Wall Street Turned to Musk’s SpaceX After Tesla’s Brief Rally

21 May 2026
Tesla shares traded near $417 Thursday afternoon, erasing early gains after SpaceX filed for an IPO and disclosed $650 million in purchases from Tesla last year. Tesla invested $2 billion in SpaceX common stock in March and reported $87 million in first-quarter revenue from SpaceX’s Megapack orders. Investors debated whether the SpaceX listing would boost or dilute Tesla’s “Musk ecosystem” premium.
Cogent Biosciences (COGT) stock jumps as FDA filing timeline sharpens — what investors watch next
Previous Story

Cogent Biosciences (COGT) stock jumps as FDA filing timeline sharpens — what investors watch next

Uber stock slips after NYC tipping report targets Uber Eats, as earnings date and new profit metrics loom
Next Story

Uber stock slips after NYC tipping report targets Uber Eats, as earnings date and new profit metrics loom

Go toTop